Autoimmune Disease Diagnostics
HumaBlot 44FA is a modern, fully automated system designed for the laboratory diagnosis of autoimmune diseases, enabling the simultaneous, highly accurate detection of a wide range of autoantibodies.
Technologies
The technology is based on the Line Immunoassay (LIA) method and automatically performs the key stages of the testing process, including sample processing, assay execution, scanning, and software-based interpretation of the results.
HumaBlot 44FA enables comprehensive assessment in the following areas:
-
ANA-LIA XL – evaluation of systemic connective tissue diseases and autoimmune rheumatic disorders;
-
ARTHRITIS-LIA – diagnosis of rheumatoid arthritis and related conditions;
-
GASTRO-LIA – detection of autoimmune gastrointestinal diseases, including celiac disease and Crohn’s disease;
-
LIVER-LIA – assessment of autoimmune liver diseases;
-
VASCULITIS-LIA – diagnosis of systemic vasculitis and related autoimmune disorders.
Autoimmune diseases often present with overlapping clinical manifestations, making it essential to evaluate not only individual biomarkers but also the complete autoantibody profile to achieve an accurate diagnosis.
The system enables physicians to obtain comprehensive diagnostic information from a single blood sample, improving diagnostic accuracy, facilitating differential diagnosis, and supporting more effective patient management.
By integrating advanced laboratory technologies with fully automated workflows, HumaBlot 44FA enhances the reliability, efficiency, and clinical value of autoimmune disease diagnostics.
